• RESTRICT-seq Reveals KAT6A Dependency in SCC Resistance

  2026-05-09

  The reference study introduces RESTRICT-seq, a time-gated CRISPR screening approach, to unravel epigenetic dependencies underlying squamous cell carcinoma (SCC) resistance. Notably, the work identifies KAT6A as a key vulnerability, providing new insight into oncogene-induced senescence and cell cycle control.

• RSL3 and Ferroptosis: Mechanistic Insights for Translational

  2026-05-08

  This article distills cutting-edge mechanistic insight and strategic guidance for translational researchers investigating ferroptosis and synthetic lethality in cancer models. Anchored by the unique capabilities of (1S,3R)-RSL3 from APExBIO, we bridge GPX4 inhibition with practical workflow recommendations, competitive positioning, and next-stage translational opportunities. With robust evidence labeling, integration of recent findings, and clear protocol guidance, this piece advances the conversation beyond standard product pages and positions RSL3 at the forefront of cancer biology innovation.

• Cell Senescence β-Galactosidase Staining Kit: Precision in A

  2026-05-08

  Discover how the Cell Senescence β-Galactosidase Staining Kit advances senescent cell detection and accelerates senolytic drug research. This in-depth analysis integrates technical insights and recent breakthroughs, offering a unique perspective for cellular aging studies.

• Dinaciclib Exploits VHL Deficiency in Clear Cell Renal Carci

  2026-05-07

  This study demonstrates that Dinaciclib, a cyclin-dependent kinase inhibitor, selectively induces cytotoxicity in VHL-deficient clear cell renal cell carcinoma (CC-RCC) cells through synthetic lethality. The research provides a mechanistic rationale for targeting vulnerabilities in CC-RCC and suggests avenues for developing precision therapies.

• Clathrin-Mediated Endocytosis in Grass Carp Reovirus Entry:

  2026-05-07

  Wang et al. (2018) systematically dissected the entry mechanism of genotype III grass carp reovirus (GCRV104), revealing that clathrin-mediated, dynamin- and pH-dependent endocytosis governs cellular uptake in kidney cells. These findings clarify the cellular pathways exploited by GCRV104, informing both antiviral strategy development and basic endocytosis research.

• Berberine Hydrochloride: Mechanistic Insights and Research P

  2026-05-06

  Berberine hydrochloride, a natural isoquinoline alkaloid, demonstrates reproducible efficacy in antibacterial, metabolic, and bone loss research. Its AMPK activation and gut-bone axis modulation are supported by recent mechanistic and clinical studies. This article details evidence, limits, and workflow parameters to optimize translational research using APExBIO's Berberine hydrochloride.

• WNT5a/GSK3/β-catenin Axis Controls Muscle FAP Adipogenesis

  2026-05-06

  This study identifies the WNT5a/GSK3/β-catenin signaling pathway as a pivotal regulator of adipogenic differentiation in muscle fibro/adipogenic progenitors (FAPs). By integrating pharmacological, single-cell, and transcriptomic approaches, the research demonstrates that modulating this axis can limit pathological fat infiltration in skeletal muscle, providing a mechanistic basis for interventions in myopathies.

• 5-hme-dCTP: Precision Tool for Plant Epigenetic DNA Modifica

  2026-05-05

  5-hme-dCTP (5-Hydroxymethyl-2’-deoxycytidine-5’-Triphosphate) is a modified nucleotide enabling controlled DNA hydroxymethylation for epigenetic research. Its use clarifies 5-hmC’s roles in plant gene expression and drought response, with robust validation for molecular biology workflows.

• ER-Fusogenic Immunogenic Liposomes Boost Cellular Immunity i

  2026-05-05

  This study introduces phosphatidylinositol-based immunogenic nanoliposomes (PI-INLs) that act dually as endogenous adjuvants and ER-targeting antigen carriers, greatly enhancing CD8 T cell responses in anti-tumor vaccine models. The work sets a new paradigm for designing self-adjuvanting nanovaccines using natural phospholipids to achieve potent, coordinated cellular immunity.

• AZ505 SMYD2 Inhibitor: Precision Tools for Epigenetic Oncolo

  2026-05-04

  Explore how AZ505, a potent and selective SMYD2 inhibitor, is redefining cancer and fibrosis research. This article unpacks unique mechanistic insights and practical assay strategies for advanced epigenetic regulation research.

• Strategic Inhibition of TGF-β/Smad in Fibrosis: A 83-01’s Tr

  2026-05-04

  This thought-leadership article explores the mechanistic and translational rationale for targeting TGF-β/Smad signaling in kidney fibrosis, spotlighting the ALK-5 inhibitor A 83-01. We synthesize recent single-cell insights on Spp1-mediated fibroblast activation, benchmark A 83-01’s selectivity and workflow compatibility, and deliver actionable guidance for translational researchers seeking high-fidelity, reproducible models of fibrosis and EMT.

• Engineering IR-1061-Loaded Polystyrene Nanoparticles for Dee

  2026-05-03

  This study demonstrates how optimizing polystyrene nanoparticle polarity and IR-1061 loading conditions yields highly emissive, stable, and biocompatible near-infrared fluorescent probes for deep in vivo imaging. The findings provide a technical advance in overcoming dye aggregation and instability, supporting more robust OTN-NIR molecular imaging applications.

• Toremifene in Breast Cancer: 20 Years of Clinical Evidence

  2026-05-02

  This review synthesizes two decades of clinical data on toremifene, a selective estrogen receptor modulator (SERM), in hormone-sensitive breast cancer. The paper highlights the evolution of endocrine therapy, the impact of pharmacogenomics, and the importance of biomarker-driven personalization, offering insights for future translational research.

• GSK J4 HCl: Advanced Insights into JMJD3 Inhibition and Immu

  2026-05-01

  Explore the multifaceted roles of GSK J4 HCl as a JMJD3 inhibitor in epigenetic regulation research. This article uniquely connects chromatin modulation to immune environment control, offering evidence-based guidance for experimental design.

• Epigenetic Induction of Spermatogonia-like Cells via Chemica

  2026-05-01

  This study presents a chemically defined protocol that elevates expression of LIM homeobox 1 (Lhx1)—a key undifferentiated spermatogonial stem cell marker—in mouse embryonic stem cells differentiated into spermatogonia-like cells. By integrating a DNA methyltransferase inhibitor (RG108) with other small-molecule modulators, the work advances in vitro recapitulation of early male germline development and provides a foundation for dissecting epigenetic mechanisms in germ cell lineage specification.

11465 records 1/765 page Next 12345 下5页 Last page